PharmaBoardroom - EMA Drugs Approved in 2019
Veterinary medicines | EMA Annual Report 2021
EMA valutazione - Fedaiisf Federazione delle Associazioni Italiane degli Informatori Scientifici del Farmaco e del Parafarmaco
Increased approvals for new active substances in the EU in 2021
To what degree are review outcomes aligned for new active substances (NASs) between the European Medicines Agency and the US Food and Drug Administration? A comparison based on publicly available information for
Variables collected for each new active substance extracted from public... | Download Scientific Diagram
New active substances approved by EMA and FDA over 10 years - ppt download
Overview of comments on RP on New Active Substance (NAS) status of chemical substances
List of medicinal products under additional monitoring
EMA offers insights on when biologics qualify as new active substances | RAPS
2021 New Drug Approvals: Review of FDA and EMA Marketing Authorisations
Human medicines: highlights of 2021 | European Medicines Agency
EMA Reflection paper on the evaluation of new active substance (NAS) status of biological substances released today
Human medicines: highlights of 2019 | European Medicines Agency
BRIEF-EMA's CHMP Approves New Manufacturing Site For Active Substance Of Nuvaxovid | Headlines
Variables collected for each new active substance extracted from public... | Download Scientific Diagram
EU Medicines Agency on Twitter: "In 2020, EMA recommended 97 #medicines for marketing authorisation. Check out our annual human medicines highlights: https://t.co/yG1yI6lO6a https://t.co/e297UmAAw3" / Twitter
Kühler et al 2019 – To what degree are review outcomes aligned for new active substances between the EMA and the US FDA? – CIRS
New EMA Sterilization guideline - GIC A3P Sterilization
Court to rule on concept of 'new active substance' in Mylan v EMA
Clinical Data Publication (Policy 0070) re-launch - EMA webinar - YouTube
To what degree are review outcomes aligned for new active substances (NASs) between the European Medicines Agency and the US Food and Drug Administration? A comparison based on publicly available information for
The EU is ready for non-biological complex medicinal products - GaBI Journal
EMA approved 89 medicines in 2022, including more ATMPs
Starting materials, active substances and active substance master files (ASMF) - YouTube
Str. 2 - SciencePharma
